about
Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator.Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.Circadian variability of insulin sensitivity: physiological input for in silico artificial pancreas.The UVA/PADOVA Type 1 Diabetes Simulator: New FeaturesMulticenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementIn silico optimization of basal insulin infusion rate during exercise: implication for artificial pancreasIn silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemiaMultinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.Diabetes: Models, Signals, and Control.Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.Physical activity into the meal glucose-insulin model of type 1 diabetes: in silico studies.Evaluating the efficacy of closed-loop glucose regulation via control-variability grid analysisModel predictive control of type 1 diabetes: an in silico trialIn silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.A system model of oral glucose absorption: validation on gold standard data.Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanismsA dynamic risk measure from continuous glucose monitoring data.A model of GLP-1 action on insulin secretion in nondiabetic subjects.The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects.DHEA in elderly women and DHEA or testosterone in elderly men.The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose.Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function.The oral minimal model method.Age-related changes in insulin sensitivity and β-cell function among European-American and African-American women.Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.A common variant in the MTNR1b gene is associated with increased risk of impaired fasting glucose (IFG) in youth with obesityAssociation between thyrotropin levels and insulin sensitivity in euthyroid obese adolescents.Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training.Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes.Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approachModeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data.Hepatic insulin sensitivity in healthy and prediabetic subjects: from a dual- to a single-tracer oral minimal model.Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer ApproachesSix and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 DiabetesGlucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling.
P50
Q27307805-A8999C0F-473F-4234-B10E-F0C1E2993D1DQ30277800-B5FD18C2-27DC-48DE-A13B-3879262782F7Q30278964-197B3814-8BD1-421C-A2A5-ABAD65FC40F8Q30301086-80057601-44B0-4D9F-ACF1-9FE030252199Q30361597-BE76545A-28F6-4358-960A-9F3A31B4DEB2Q30370613-CAAA7E90-2476-4D29-9082-151AD4DB4BEBQ30384405-92419B9F-DD9A-41E1-A9A9-BF0E32C3C452Q30409243-F35F47F1-BB12-4A33-B78E-E887AAB41263Q30409811-BC436A3F-1889-4BA8-8928-B6DF28A03F2AQ30410405-D5C0B87E-C470-4C04-8FDA-5241D54CB92BQ30417379-5E8B08C8-97DE-4AFA-9A7D-652AF63A665EQ30429989-F014C901-047C-4DAE-9A28-40202E6C2DD0Q30434551-51B39972-0B73-45DA-BD89-4C6E9256CDE3Q30434940-E044BC7A-494E-49F1-BF5D-F51108E7B354Q30437503-C700A510-CA03-4CAC-99D7-1A1B4E41D780Q30437978-09679A07-2E82-4596-9337-D0281CB45735Q30437991-591DD2FC-AF10-4515-A46B-90AE1A24FD2AQ30439654-E42861C2-4D58-409E-80D5-779DD5F1359CQ31083425-E704C9C7-DA40-4E1F-B19D-68047CEC9CDCQ33750602-4742FBE9-12F2-4FA8-8469-902829487DD1Q33895702-85292B09-BB91-4C96-90FC-F87EC7E0D03BQ33916585-6E1B9635-910A-4B4D-9BCC-EC23289466E3Q33921797-8914180A-16B4-4113-9A0B-CD570A812A7DQ34000294-DAEDCB82-9F65-4AC0-A6D9-5C5327DE2930Q34014522-A4853454-A2E9-4910-9DBB-75A18BE24742Q34200880-FF3D15B6-CF0D-4CDE-B20F-73CCF3017D4FQ34263966-2844982A-FFAA-4042-ADDF-046F7DA1BC67Q34781491-428D9097-0F4C-4527-9318-2F99BFB03519Q35215184-2691EAF6-E2C9-4B46-BB62-EF735B782DEEQ35551571-4BC2C79D-9075-4434-A088-FB2725B95A74Q35589813-6F519E17-00DE-4776-AB16-6CBAD875C5CDQ35630850-40AA1D12-5947-4823-8A7C-C5ABDE7D50F6Q35744498-3284CE7D-4B75-4565-975D-63283C148E3AQ35749422-9A866900-1FE8-47F6-BE28-86BE403D47A8Q35757262-235E183E-EDFB-4287-8591-ADA0B2E92871Q35859162-A5993A5C-3962-4466-AB19-765B3D84D9B8Q35927919-D3516923-9F62-4785-82F4-5A153CBC4358Q35992525-9541E611-91A5-45BC-AD76-8F967EC07519Q36017577-03F07A1F-99F3-4D0F-9CF6-21DE31112472Q36182573-6DB6FE42-87D1-4069-98DA-DE59EB7B453F
P50
description
scholar from Padova
@en
name
Chiara Dalla Man
@ast
Chiara Dalla Man
@en
Chiara Dalla Man
@es
Chiara Dalla Man
@nl
type
label
Chiara Dalla Man
@ast
Chiara Dalla Man
@en
Chiara Dalla Man
@es
Chiara Dalla Man
@nl
prefLabel
Chiara Dalla Man
@ast
Chiara Dalla Man
@en
Chiara Dalla Man
@es
Chiara Dalla Man
@nl
P214
P1960
uzVhBzsAAAAJ
P2038
Chiara_Dalla_Man
P21
P214
P31
P396
IT\ICCU\CFIV\275261
P569
1977-01-01T00:00:00Z
P735
P7859
viaf-307345281